Sign in
Taking people in United StatesNo phase

Comparing gut and skin bacteria in people with vitiligo and healthy people

Compares gut and skin microbes in people with vitiligo and healthy adults.

Key facts

Who runs it
Northwestern University
Where
Chicago, United StatesSee the site
Trial code
Registry title
The Gut and Skin Microbiome in Vitiligo Disease Progression
Status
Recruiting
People taking part
100 people, planned
Started
30 May 2019
Expected to end
Dec 2026
Type of study
Observational, 2 groups
Record updated
9 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with vitiligo, with active or stable disease, and adults without vitiligo of similar age and sex. It compares the bacteria in the gut and on the skin.

Age
18 to 89 years
Sex
All sexes
Disease stage
Vitiligo with or without spreading of the patches over the past year. People without vitiligo can join as a comparison group.

Main reasons for not taking part

  • Younger than 18 years or 90 years or older
  • Not able to give consent

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients with and/or without vitiligo lesional expansion over the past year
  • Age/sex-matched controls who do not have a diagnosis of vitiligo
  • Subjects who are age 18-89 years of age at time of enrollment
  • Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443)

Who cannot take part

  • Subjects who are younger than 18 years of age or 90 years of age or older
  • Subjects who are unable to give consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 89 years old?

Where in United States

  • Northwestern UniversityChicago, United StatesContact: Dermatology CTUTaking people

About the trial

What the trial wants to find out

Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.

The 2 groups in the trial

  • Adults with vitiligo
  • Healthy adults

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Gut and Skin Microbiome in Vitiligo Disease Progression
Plain-language title
Comparing gut and skin bacteria in people with vitiligo and healthy peopleGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT03577327, who can take part
Record updated
9 June 2026